BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19133578)

  • 1. [Risk with strict glucose control and hydroxyethyl starch in severe sepsis. Routine intensive care treatments are now questioned].
    Berggren L
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3516-7. PubMed ID: 19133578
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin and pentastarch for severe sepsis.
    Bracco D; Schricker T; Carvalho G
    N Engl J Med; 2008 May; 358(19):2072; author reply 2074-5. PubMed ID: 18467982
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin and pentastarch for severe sepsis.
    Muller L; Jaber S; Lefrant JY
    N Engl J Med; 2008 May; 358(19):2072-3; author reply 2074-5. PubMed ID: 18467981
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin and pentastarch for severe sepsis.
    Ellger B; van den Heuvel I; Poelaert J
    N Engl J Med; 2008 May; 358(19):2073-4; author reply 2074-5. PubMed ID: 18467980
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal failure in septic patients receiving hydroxyethyl starch.
    Wiedermann CJ
    Minerva Anestesiol; 2007; 73(7-8):441; author reply 442. PubMed ID: 17637590
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyethyl starches should not be used in critically ill patients.
    Johnston M; Clarke L
    J R Army Med Corps; 2008 Sep; 154(3):214. PubMed ID: 19205089
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin and pentastarch for severe sepsis.
    Van den Berghe G; Wilmer A; Bouillon R
    N Engl J Med; 2008 May; 358(19):2073; author reply 2074-5. PubMed ID: 18467979
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on reference to maximum dose for starch.
    Bennett-Guerrero E; Gan TJ; Roche AM; Mythen MG
    Anesthesiology; 2010 Mar; 112(3):757-8; author reply 758-60. PubMed ID: 20179520
    [No Abstract]   [Full Text] [Related]  

  • 9. Individual patient data meta-analysis of hydroxyethyl starch 130/0.4-0.42 versus crystalloid for fluid resuscitation in patients with severe sepsis: a statistical analysis plan.
    Hammond NE; Haase N; Billot L; Wetterslev J; Saxena MK; Finfer S; Perner A; Myburgh J
    Crit Care Resusc; 2014 Jun; 16(2):96-103. PubMed ID: 24888279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyethyl starches: Plus ça change, plus c'est la même chose.
    Reinhart K; Hartog CS; Brunkhorst FM
    Anesthesiology; 2010 Mar; 112(3):756-7. PubMed ID: 20179519
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch.
    Shaw AD; Kellum JA
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):497-503. PubMed ID: 23335037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelatin solutions for critically unwell septic adults.
    Patel A; Brett SJ
    Br J Hosp Med (Lond); 2013 Nov; 74(11):657. PubMed ID: 24220537
    [No Abstract]   [Full Text] [Related]  

  • 13. Iatrogenic hypoalbuminemia due to hydroxyethyl starch 130/0.4: a risk factor for acute kidney injury?
    Wiedermann CJ
    Anesth Analg; 2010 Apr; 110(4):1242; author reply 1243. PubMed ID: 20357164
    [No Abstract]   [Full Text] [Related]  

  • 14. Exclusion of suspect data raises question mark over safety of common plasma substitute.
    Mayor S
    BMJ; 2013 Feb; 346():f1132. PubMed ID: 23423548
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of hydroxyethyl starch in resuscitation in the ICU.
    Myburgh J
    Crit Care Resusc; 2012 Dec; 14(4):251-2. PubMed ID: 23230872
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
    Brunkhorst FM; Engel C; Bloos F; Meier-Hellmann A; Ragaller M; Weiler N; Moerer O; Gruendling M; Oppert M; Grond S; Olthoff D; Jaschinski U; John S; Rossaint R; Welte T; Schaefer M; Kern P; Kuhnt E; Kiehntopf M; Hartog C; Natanson C; Loeffler M; Reinhart K;
    N Engl J Med; 2008 Jan; 358(2):125-39. PubMed ID: 18184958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
    Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
    J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydroxyethyl starch. HAES 200/0,5--a new plasma substitute].
    Jacobsen JK; Jørgensen L; Nielsen SL
    Ugeskr Laeger; 1993 Jul; 155(28):2220-4. PubMed ID: 7687076
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 20. Strict glucose control in the cardiac intensive care unit poised for real time?
    Kapoor JR; Kapoor R
    J Am Coll Cardiol; 2009 Jul; 54(4):373-4; author reply 374. PubMed ID: 19608039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.